Ruxolitinib withdrawal complicating emergency aortic root replacement.
Aortic syndrome
Cardiac surgery
Ruxolitinib
Journal
Interactive cardiovascular and thoracic surgery
ISSN: 1569-9285
Titre abrégé: Interact Cardiovasc Thorac Surg
Pays: England
ID NLM: 101158399
Informations de publication
Date de publication:
15 06 2022
15 06 2022
Historique:
received:
10
02
2022
revised:
18
04
2022
accepted:
24
05
2022
pubmed:
1
6
2022
medline:
22
6
2022
entrez:
31
5
2022
Statut:
ppublish
Résumé
Ruxolitinib, a Janus kinase inhibitor, is associated with severe withdrawal phenomena. Adequate tapering is often underemphasized in surgical emergencies and can complicate the postoperative course. We present a case of acute ruxolitinib withdrawal in a gentleman undergoing emergency cardiac surgery.
Identifiants
pubmed: 35640536
pii: 6595024
doi: 10.1093/icvts/ivac143
pmc: PMC9201970
pii:
doi:
Substances chimiques
Nitriles
0
Pyrazoles
0
Pyrimidines
0
ruxolitinib
82S8X8XX8H
Types de publication
Case Reports
Journal Article
Langues
eng
Sous-ensembles de citation
IM
Informations de copyright
© The Author(s) 2022. Published by Oxford University Press on behalf of the European Association for Cardio-Thoracic Surgery.
Références
Int J Hematol. 2014 Nov;100(5):498-501
pubmed: 25034748
Sci Adv. 2018 Nov 28;4(11):eaat3834
pubmed: 30498775
Crit Care. 2020 Feb 4;24(1):36
pubmed: 32019600
Drugs. 2017 Apr;77(5):521-546
pubmed: 28255960
Am Heart J. 2015 Aug;170(2):409-18
pubmed: 26299240
Circulation. 2021 Feb 2;143(5):e35-e71
pubmed: 33332149
Front Immunol. 2020 Jul 10;11:1648
pubmed: 32754159